SNPS Stock - Synopsys, Inc.
Unlock GoAI Insights for SNPS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $7.05B | $6.13B | $5.33B | $4.62B | $4.20B |
| Gross Profit | $5.24B | $4.88B | $4.10B | $3.72B | $3.30B |
| Gross Margin | 74.3% | 79.7% | 76.9% | 80.5% | 78.7% |
| Operating Income | $914.93M | $1.36B | $1.37B | $1.15B | $753.64M |
| Net Income | $1.34B | $2.26B | $1.23B | $984.59M | $757.52M |
| Net Margin | 19.0% | 36.9% | 23.1% | 21.3% | 18.0% |
| EPS | $8.13 | $14.78 | $8.08 | $6.44 | $4.96 |
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, it provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, the company offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. It serves electronics, financial services, automotive, medicine, energy, and industrial areas. The company was incorporated in 1986 and is headquartered in Mountain View, California.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 11th 2025 | BofA Securities | Upgrade | Buy | $560 |
| December 9th 2025 | Rosenblatt | Upgrade | Buy | $560 |
| December 8th 2025 | BofA Securities | Upgrade | Neutral | $500 |
| November 24th 2025 | Citigroup | Initiation | Buy | $580 |
| September 10th 2025 | Needham | Reiterated | Buy | $550← $660 |
| September 10th 2025 | Rosenblatt | Downgrade | Neutral | $605 |
| September 10th 2025 | Robert W. Baird | Downgrade | Neutral | $535 |
| September 10th 2025 | BofA Securities | Downgrade | Underperform | $525 |
| July 10th 2025 | Goldman | Initiation | Buy | $620 |
| January 13th 2025 | Redburn Atlantic | Initiation | Buy | $600 |
| November 22nd 2024 | Wells Fargo | Initiation | Equal Weight | $570 |
| November 12th 2024 | Loop Capital | Initiation | Buy | $675 |
| October 22nd 2024 | Mizuho | Initiation | Outperform | $650 |
| October 15th 2024 | Berenberg | Initiation | Buy | $660 |
| April 4th 2024 | Piper Sandler | Initiation | Overweight | $665 |
Earnings History & Surprises
SNPSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 26, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | $3.57 | — | — | — |
Q4 2025 | Dec 10, 2025 | $2.78 | $2.90 | +4.3% | ✓ BEAT |
Q3 2025 | Sep 9, 2025 | $3.80 | $3.39 | -10.8% | ✗ MISS |
Q2 2025 | May 28, 2025 | $3.39 | $3.67 | +8.3% | ✓ BEAT |
Q1 2025 | Feb 26, 2025 | $2.79 | $3.03 | +8.6% | ✓ BEAT |
Q4 2024 | Dec 4, 2024 | $3.30 | $3.40 | +3.0% | ✓ BEAT |
Q3 2024 | Aug 21, 2024 | $3.28 | $3.43 | +4.6% | ✓ BEAT |
Q2 2024 | May 22, 2024 | $2.95 | $3.00 | +1.7% | ✓ BEAT |
Q1 2024 | Feb 21, 2024 | $3.43 | $3.56 | +3.8% | ✓ BEAT |
Q4 2023 | Nov 29, 2023 | $3.04 | $3.17 | +4.3% | ✓ BEAT |
Q3 2023 | Aug 16, 2023 | $2.73 | $2.88 | +5.5% | ✓ BEAT |
Q2 2023 | May 17, 2023 | $2.47 | $2.54 | +2.8% | ✓ BEAT |
Q1 2023 | Feb 15, 2023 | $2.50 | $2.62 | +4.8% | ✓ BEAT |
Q4 2022 | Nov 30, 2022 | $1.84 | $1.91 | +3.8% | ✓ BEAT |
Q3 2022 | Aug 17, 2022 | $2.04 | $2.10 | +2.9% | ✓ BEAT |
Q2 2022 | May 18, 2022 | $2.37 | $2.50 | +5.5% | ✓ BEAT |
Q1 2022 | Feb 16, 2022 | $2.37 | $2.40 | +1.3% | ✓ BEAT |
Q4 2021 | Dec 1, 2021 | $1.78 | $1.82 | +2.2% | ✓ BEAT |
Q3 2021 | Aug 18, 2021 | $1.78 | $1.81 | +1.7% | ✓ BEAT |
Latest News
Morgan Stanley Maintains Overweight on Synopsys, Raises Price Target to $550
📈 PositiveJP Morgan Maintains Overweight on Synopsys, Raises Price Target to $650
📈 PositiveWells Fargo Maintains Equal-Weight on Synopsys, Raises Price Target to $500
➖ NeutralKeybanc Maintains Overweight on Synopsys, Raises Price Target to $600
📈 PositiveB of A Securities Upgrades Synopsys to Buy, Raises Price Target to $560
📈 PositiveRosenblatt Maintains Buy on Synopsys, Maintains $560 Price Target
📈 PositiveNeedham Maintains Buy on Synopsys, Raises Price Target to $580
📈 PositivePiper Sandler Maintains Overweight on Synopsys, Lowers Price Target to $602
➖ NeutralSynopsys shares are trading higher after the company reported better-than-expected Q4 results and issued Q1 guidance above estimates.
📈 PositiveSynopsys Non-GAAP EPS of $2.90 beats by $0.02, revenue of $2.37B beats by $130M
📈 PositiveSynopsys Sees FY2026 Adj EPS $14.32-$14.40 vs $12.85 Est; Sees Sales $9.560B-$9.660B vs $7.044B Est
📈 PositiveSynopsys Sees Q1 Adj EPS $3.52-$3.58 vs $3.31 Est; Sees Sales $2.365B-$2.415B vs $2.378B Est
📈 PositiveSynopsys Q4 Adj. EPS $2.90 Beats $2.78 Estimate, Sales $2.255B Beat $2.247B Estimate
📈 PositiveRosenblatt Upgrades Synopsys to Buy, Lowers Price Target to $560
📈 PositiveB of A Securities Upgrades Synopsys to Neutral, Lowers Price Target to $500
➖ NeutralKeybanc Maintains Overweight on Synopsys, Lowers Price Target to $575
➖ NeutralSynopsys CEO Says NVIDIA's $2B Investment In Synopsys Does Not Contain Any Commitments To Purchase NVIDIA Chips; NVIDIA CEO Says Investment In Synopsys Is A "Demonstration Of Commitment" To Synopsys For "Going All In On The NVIDIA Platform"
📈 PositiveNvidia invests $2B in Synopsys stock; companies team up over engineering and design
📈 PositiveSynopsys shares are trading higher after the company announced a partnership with NVIDIA and said NVIDIA will invest $2B in Synopsys common stock at $414.79 per share.
📈 PositiveNVIDIA And Synopsys Announce Partnership; NVIDIA Invests $2B In Synopsys Common Stock At $414.79/share
📈 PositiveFrequently Asked Questions about SNPS
What is SNPS's current stock price?
What is the analyst price target for SNPS?
What sector is Synopsys, Inc. in?
What is SNPS's market cap?
Does SNPS pay dividends?
Similar Stocks
Technology SectorExplore stocks similar to SNPS for comparison